microangiopathic hemolytic anemia maha microangiopathic subgroup hemolytic anemia loss red blood cells destruction caused factors small blood vessels identified finding anemia schistocytes microscopy blood film diseases hemolytic uremic syndrome disseminated intravascular coagulation thrombotic thrombocytopenic purpura malignant hypertension endothelial layer small vessels damaged resulting fibrin deposition platelet aggregation red blood cells travel damaged vessels fragmented resulting intravascular hemolysis resulting schistocytes red cell fragments also increasingly targeted destruction reticuloendothelial system spleen due narrow passage obstructed vessel lumina seen systemic lupus erythematosus immune complexes aggregate platelets forming intravascular thrombi microangiopathic hemolytic anemia also seen microangiopathic hemolytic anemia may suspected based routine medical laboratory tests cbc complete blood cell count automated analysers machines perform routine full blood counts hospitals designed flag blood specimens contain abnormal amounts red blood cell fragments causes mechanism maha formation fibrin mesh due increased activation system coagulation red blood cells physically cut protein networks resulting fragments schistocytes observed light microscopy microangiopathic hemolytic anemia results isolated increase serum bilirubin levels unconjugated hyperbilirubinemia present differential diagnoses rifampicin probenecid use inherited disorders like gilberts syndrome hemolytic disorders peripheral smears fragmented rbcs burr cells helmet cells triangle cells platelets cryoprecipitate contraindicated facilitate clot formation rbc lysis plasmapheresis one treatment ttp corticosteroids also considered mcn httpsenwikipediaorgwikimicroangiopathichemolyticanemia